Latest blood clots Stories
FDA now requires general product label warnings about increased risk ALTON, Ill., June 24, 2014 /PRNewswire/ -- The U.S.
The US Food and Drug Administration (FDA) is now requiring manufacturers of testosterone supplements to include a general warning label about the risk of blood clots in the veins.
With over 100 Testosterone Treatment Lawsuits Pending Litigation, The FDA Continues Its Investigation Into The Potential Health Risks of Testosterone Replacement Therapy Drugs Reports Wright &
A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City has found that atrial fibrillation patients who are on blood thinning medications are at higher risk of developing dementia if their doses are not in the optimal recommended range.
Interventional cardiologists and electrophysiologists at Allegheny General Hospital recently performed the first procedure using the LARIAT™ Suture Delivery Device, a lasso-like suture that
RARITAN, N.J., March 31, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today it is adding three new clinical trials to its EXPLORER global cardiovascular research
Insufficient medical care of blood clots in the extremities is prevalent, but Dr.
Susquehanna Health (SH) Cardiothoracic Surgeon Dr.
The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news.
Ultrasound-stimulated microbubbles have been showing promise in recent years as a non-invasive way to break up dangerous blood clots.
- A transitional zone between two communities containing the characteristic species of each.